Balchem has launched a choline-enriched folate ingredient called Optifolin+

Mother and son. Image courtesy of Balchem.

Balchem (Montvale, NJ) has announced the launch of Optifolin+, a bioactive, choline-enriched folate (L-5-methyltetrahydrofolate; L-5-MTHF). The ingredient combines L-5-MTHF with Balchem’s branded choline (VitaCholine) to support cellular health across life stages; from pregnancy and early childhood to adulthood.

“We’re excited to introduce Optifolin+ to the nutraceutical market – and the timing couldn’t be better. The women’s health market is witnessing significant growth, driven by the desire for tailored solutions to address gender-specific needs through all life stages,” said Frederic Boned, senior vice president and general manager, Balchem Human Nutrition and Health, in a press release. “Folate supplementation is widely recognized as being crucial from the preconceptional period, through pregnancy and breastfeeding, since it plays a key role in supporting the health of moms and babies every step of the way. Adequate folate intake also helps maintain homocysteine levels, which contributes to preserving brain health and cognitive function as we age. While there are existing folate solutions available on the market, Optifolin+ is the first choline-enriched salt in this space. This unique folate and choline combination has seven times the methyl groups than other folate brands, and is critical to building and preserving genetic material which help support prenatal, heart, and brain health.”

According to Balchem, its patented L-5-MTHF had 98% active methylating nutrients to provide seven times the methyl groups found in other folate products. “The folate supplement market is poised to evolve from one-size-fits-all to personalized solutions that meet individual needs and maximize health benefits. With Optifolin+, manufacturers can seize the moment and pave the way for next-generation tailored solutions that help maintain the integrity of human health and body repair. Optifolin+ will be initially launched in the US, where it has received the NDIN (New Dietary Ingredient Notification) and patent protection,” explained Dominik Mattern, vice president, science, business development and marketing for Balchem Human Nutrition and Health. “Following our recent brand refresh, Optifolin+ joins our redefined Human Nutrition & Health portfolio, enriching Balchem’s wide range of vitamins and minerals. And we see a promising avenue ahead as we explore the synergies between Optifolin+ and our other flagship ingredients.”